These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 18854954)
1. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization. Zhang M; Yu D; Yang C; Xia Q; Li W; Liu B; Li H Pharm Res; 2009 Jan; 26(1):204-10. PubMed ID: 18854954 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology study of a chimeric decoy receptor trap fusion protein on retina neovascularization by dual blockage of VEGF and FGF-2. Jiang J; Xu K; Wang L; Xin W; Zhao G; Huang M; Li S; Luan X; Fang J Eur J Pharm Sci; 2018 Aug; 121():251-259. PubMed ID: 29715501 [TBL] [Abstract][Full Text] [Related]
3. Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys. Zhang M; Zhang J; Yan M; Li H; Yang C; Yu D Mol Vis; 2008 Jan; 14():37-49. PubMed ID: 18246030 [TBL] [Abstract][Full Text] [Related]
4. A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Zhang M; Zhang J; Yan M; Luo D; Zhu W; Kaiser PK; Yu DC; Ophthalmology; 2011 Apr; 118(4):672-8. PubMed ID: 21146224 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878 [TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta. Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats. Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022 [TBL] [Abstract][Full Text] [Related]
9. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates. Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic effect of KH902 on retinal neovascularization. Wang F; Bai Y; Yu W; Han N; Huang L; Zhao M; Zhou A; Zhao M; Li X Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520 [TBL] [Abstract][Full Text] [Related]
11. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases. Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A Acta Ophthalmol; 2008 Nov; 86 Thesis 4():42-9. PubMed ID: 19032681 [TBL] [Abstract][Full Text] [Related]
13. IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys. Ren X; Li J; Xu X; Wang C; Cheng Y Exp Eye Res; 2016 Apr; 145():352-358. PubMed ID: 26919788 [TBL] [Abstract][Full Text] [Related]
14. KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF. Chen X; Li J; Li M; Zeng M; Li T; Xiao W; Li J; Wu Q; Ke X; Luo D; Tang S; Luo Y Diabetes Obes Metab; 2013 Mar; 15(3):224-33. PubMed ID: 22958404 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Gu L; Chen H; Tuo J; Gao X; Chen L Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960 [TBL] [Abstract][Full Text] [Related]
19. Profile of conbercept in the treatment of neovascular age-related macular degeneration. Lu X; Sun X Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634 [TBL] [Abstract][Full Text] [Related]
20. In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System. Osswald CR; Guthrie MJ; Avila A; Valio JA; Mieler WF; Kang-Mieler JJ Curr Eye Res; 2017 Sep; 42(9):1293-1301. PubMed ID: 28557571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]